Vow ASA
Maria Therese Victoria Badin, who is a related party of the CEO of Vow ASA, Mr. Henrik Badin, has today purchased 2 650 shares at a price of NOK 38.30 per share. After this transaction, Ms. Badin controls 39 999 shares in the Company. Mr. Henrik Badin controls, in addition, 10 500 000 shares in the Company through his 100 % owned company Badin Invest Ltd.
For further queries, please contact
Vow ASA
Erik Magelssen - CFO
Tel: + 47 928 88 728
Email: erik.magelssen@vowasa.com
About Vow ASA
In Vow and our subsidiaries Scanship and Etia we are passionate about preventing pollution. Our world leading solutions convert biomass and waste into valuable resources and generate clean and CO2 neutral energy for a wide range of industries.
Cruise ships on every ocean have Vow technology inside which processes waste and purifies wastewater. Fish farmers are adopting similar solutions, and public utilities and industries use our solutions for sludge processing, waste management and biogas production on land.
Our ambitions go further than this. With our advanced technologies and solutions, we turn waste into biogenetic fuels to help decarbonize industry and convert plastic waste into fuel, clean energy and high-value pyro carbon. Our solutions are scalable, standardized, patented and thoroughly documented, and our capability to deliver is well proven. They are key to end waste and stop pollution.
Located in Oslo, the parent company Vow ASA is listed on the Oslo Stock Exchange (ticker VOW from 13 January 2020).
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
King Faisal Prize7.1.2026 19:01:34 CET | Press release
Pioneering Scientist Behind Revolutionary Weight-Loss Drugs and Leading Mathematician Honored with 2026 King Faisal Prize
Herantis Pharma plc7.1.2026 19:01:06 CET | Press release
Herantis Pharma - Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease
Theon International PLC7.1.2026 18:43:56 CET | Press release
THEON completes the acquisition of a circa 9.8% stake in Exosens
Modelo7.1.2026 18:41:51 CET | Press release
UPDATE - Big Flavor, Zero Compromise: Modelo® Debuts First-Ever Non-Alcoholic Option
VALLOUREC7.1.2026 18:00:00 CET | Press release
VALLOUREC INITIATES A €200 MILLION SHARE BUYBACK AND TARGETS TOTAL SHAREHOLDER RETURN TO BE AT LEAST €500 MILLION BY AUGUST 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
